Physician profile
Harry Lightfoot
NPI 1205848272
$241,077.75
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70K · 2020: $69K · 2021: $38K · 2022: $52K · 2023: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $464.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $240,134.66 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $328.80 | 2019-2022 | |
| Davol INC. | $152.95 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $78.40 | 2021 | |
| Acera Surgical, INC. | $75.53 | 2019-2020 | |
| Baxter Healthcare | $56.37 | 2021 | |
| Integra Lifesciences Corporation | $46.05 | 2020-2021 | |
| Acell, INC. | $40.34 | 2019-2020 | |
| Depuy Synthes Sales INC. | $27.11 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $24.58 | 2020 | |
| Prescient Surgical | $22.33 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.97 | 2021 | |
| Medtronic USA, INC. | $21.76 | 2019 | |
| Smith+Nephew, INC. | $17.62 | 2019 | |
| Teleflex LLC | $15.71 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Lightfoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.